Natriuretic Peptides and Remodeling in Heart Failure

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Since the discovery of the cardiac hormone ANP, the field of natriuretic peptides has significantly advanced with translation of new knowledge to the clinical practice of heart failure (HF). This new knowledge has underscored the importance of cardiorenal mechanisms that contribute to optimal cardiovascular homeostasis. Work has also established direct myocardial actions broadening their therapeutic potential beyond renal mechanisms. Indeed, one such therapeutic target is cardiac remodeling and fibrosis based upon the unique cardiorenal protective properties. The objective of this article is to review new insights into the use of natriuretic peptides as novel therapeutic agents for cardiorenal protection in progressive HF, which serves to limit cardiac remodeling and fibrosis and thus the progression of HF.

Original languageEnglish (US)
Pages (from-to)129-139
Number of pages11
JournalHeart Failure Clinics
Volume1
Issue number1
DOIs
StatePublished - Apr 1 2005

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this